Rajanikant Gulabdas Patel's most recent trade in Lincoln Pharmaceuticals Ltd. was a Acquisition of 31,400 Equity Shares done at an average price of Rs. 317.8 . Disclosure was reported to the exchange on March 14, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Rajanikant Gulabdas Patel's has made SAST transactions in Lincoln Pharmaceuticals Ltd. recently where a Acquisition of 420,001 shares done . Disclosure was reported to the exchange on March 14, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lincoln Pharma | Rajanikant Gulabdas Patel | Other | Acquisition | 21 Mar 2022 | 420,001 | - | 2.10% | - | 12 Mar 2020 12 Mar 2020 |
SAST (10(6)) | - | - | |
| Lincoln Pharma | Rajanikant Gulabdas Patel | Promoter | Acquisition | 15 Mar 2022 | 31,400 | 756,801 (3.78%) | 0.16% | - | 11 Mar 2022 11 Mar 2022 |
SAST (29(2)) | - | Inter-se Transfer | |
| Lincoln Pharma | Rajanikant Gulabdas Patel | Promoter & Director | Acquisition | 14 Mar 2022 | 31,400 | 756,801 (3.78%) | 0.16% | 317.8 | 9,978,920 | 11 Mar 2022 11 Mar 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Lincoln Pharma | Rajanikant Gulabdas Patel | Promoter | Acquisition | 05 Mar 2022 | 31,400 | - | 0.16% | - | 10 Mar 2022 10 Mar 2022 |
SAST (10(1)(a)) | - | None |